Bone morphogenetic protein 2 is a new molecular target linked to non-alcoholic fatty liver disease with potential value as non-invasive screening tool
2022 · Biomarker Research · 7 citations
https://doi.org/10.1186/s40364-022-00383-3
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
12
Papers
28
Citations
3
h-index
0
i10-index
Carlos Ernesto Fernández-García is an academic researcher. The author has contributed to research in topics: Liver Disease Diagnosis and Treatment & Obstructive Sleep Apnea Research & Liver physiology and pathology. The author has an h-index of 3, co-authored 11 publications.
ORCID: 0000-0001-6180-879Xhttps://doi.org/10.1186/s40364-022-00383-3
https://doi.org/10.1186/s40364-025-00862-3
Click to start Chat